Cantilever Investors logo
  • Home
  • About
  • Investor Network
  • Portfolio
  • Business partners
  • Contact

News

Novolux Awarded "Up and Coming" Prize!

December 8, 2020

Gathering more than 500 attendees at the Detroit Masonic Temple, the 8th Annual Accelerate Michigan Innovation Competition awarded close to $1M in cash and in-kind services from WeWork, Varnum, Lambert & Edwards, Google, and Plante Moran to 11 Michigan-based companies.

(among others) Novolux BioSciences (Houghton) won the Up & Coming Prize of $20,000 + in-kind services from sponsors. The company makes dyes brighter in the discovery and recognition of flow cytometry.

Light Line Medical Recognized as ‘Most Valued Company’ at virtual Keiretsu Forum Investor Capital Expo

November 6, 2020

SEATTLE, WA—Light Line Medical, which has developed a proprietary method of delivering light to prevent and treat catheter-associated infections, was recognized as one of the top three ‘Most Valued Company’ at the Keiretsu Forum Investor Capital Expo that is showcasing 36 late-stage growth companies seeking funding.

Nearly 50 angel groups, investors from 100+ Family Offices, corporate partners, and hundreds of accredited investors have attended the first two sessions of the Expo. Continue Reading.

Acurx Announces All Patients Demonstrated Clinical and Sustained Cure in Ph2A Open-Label Trial of Ibezapolstat for Treatment of C. difficile Infection (CDI)

November 5, 2020

WHITE PLAINS, N.Y., Nov. 5, 2020 /PRNewswire/ -- Acurx Pharmaceuticals, LLC ("Acurx" or the "Company"), a privately held, clinical-stage biopharmaceutical company developing an entirely new class of antibiotics for difficult-to-treat bacterial infections, announced that all 10 patients (100%) with mild-to-moderate CDI enrolled in this Ph2A open-label clinical trial met the study's primary and secondary efficacy endpoints following treatment with orally administered ibezapolstat given 450 mg twice daily for 10 days. Continue Reading.

New boost for high-brightness dyes research

October 20, 2020

StabiLux Biosciences, a spin-out company from research conducted at Michigan Technological University, has received an additional $500,000 supplementary grant from the National Science Foundation (NSF). Continue Reading.

New Boost for High-brightness Dyes Research

October 19, 2020

StabiLux Biosciences, a spin-out company from research conducted at Michigan Technological University, has received an additional $500,000 supplementary grant from the National Science Foundation (NSF).

his new NSF Small Business Technology Transfer (STTR) Phase IIB project, led by Nazmiye Yapici, Ph.D. ‘13, and Dongyan Zhang, adjunct associate professor in physics, will support the commercialization of high-brightness dyes for medical uses. Continue Reading.

Congratulations to Pathware

May 16, 2019

Congratulations to Pathware on their solid pitch efforts winning the Best Pitch Prize at TCnewtech.org!  Pathware is providing the technology necessary for hospitals to perform successful biopsies on the first attempt, every time.TCnewtech.org would also like to thank Cantilever, as this month's Best Pitch Prize sponsor! 

Cantilever Business Partners is a true business partnership between their company, investors within their capital fund, startup business founders and visionaries, and a network of independent professionals. 

WMU-born smart helmet technology earns Michigan small business honors for Portage company

May 15, 2019

Recently a ruling came out to limit the number of hits high school football players can get at practice," Tokarz said in the announcement on the award. "But what type of hits are we limiting? Continue Reading.

StabiLux Biosciences Receives $650,000 in Funding

November 7, 2017

StabiLux Biosciences (Novolux), a company founded by Michigan Technological University physics professor  Yoke Khin Yap,  has recently been awarded more than $650,000. Continue Reading.

Connect

© 2021 Cantilever Investors Powered by Jottful